Utah Medical Products Inc's Comment on Supply Chain
UTMD sources most components from various global vendors and maintains safety stocks to mitigate supply chain disruptions, including those resulting from government policy changes and tariffs. The company carries additional inventory during uncertain periods and actively seeks alternative sourcing options. Vendors are qualified through UTMD's Quality Assurance program, and in sole-source situations, agreements include provisions for excess safety stocks. UTMD implements a vendor quality monitoring program to verify that incoming materials meet specifications.
UTMD operates four overseas facilities located in Romsey, Hampshire, England; Castle Hill, New South Wales, Australia; Mississauga, Ontario, Canada; and Athlone, County Westmeath, Ireland. These facilities support marketing, regulatory compliance, and manufacturing capacity. The company imports proprietary Filshie devices from its Ireland manufacturing subsidiary for distribution in the United States, where these products are subject to a 15% tariff. To reduce tariffs and taxes, UTMD plans to shift overseas orders to its Ireland manufacturing facility in 2026.
Utah Medical Products Inc's Comment on Supply Chain
UTMD sources most components from various global vendors and maintains safety stocks to mitigate supply chain disruptions, including those resulting from government policy changes and tariffs. The company carries additional inventory during uncertain periods and actively seeks alternative sourcing options. Vendors are qualified through UTMD's Quality Assurance program, and in sole-source situations, agreements include provisions for excess safety stocks. UTMD implements a vendor quality monitoring program to verify that incoming materials meet specifications.
UTMD operates four overseas facilities located in Romsey, Hampshire, England; Castle Hill, New South Wales, Australia; Mississauga, Ontario, Canada; and Athlone, County Westmeath, Ireland. These facilities support marketing, regulatory compliance, and manufacturing capacity. The company imports proprietary Filshie devices from its Ireland manufacturing subsidiary for distribution in the United States, where these products are subject to a 15% tariff. To reduce tariffs and taxes, UTMD plans to shift overseas orders to its Ireland manufacturing facility in 2026.
Sources:
Utah Medical Products Inc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Utah Medical Products Inc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
